Product NDC: | 0069-0094 |
Proprietary Name: | Vecuronium Bromide |
Non Proprietary Name: | Vecuronium Bromide |
Active Ingredient(s): | 10 mg/1 & nbsp; Vecuronium Bromide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0094 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090243 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110511 |
Package NDC: | 0069-0094-02 |
Package Description: | 10 VIAL in 1 BOX (0069-0094-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Code | 0069-0094-02 |
Proprietary Name | Vecuronium Bromide |
Package Description | 10 VIAL in 1 BOX (0069-0094-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Product NDC | 0069-0094 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Vecuronium Bromide |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110511 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | VECURONIUM BROMIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |